Willow Biosciences Inc.
CANSF
$0.0038
$0.001140.74%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 635.90K | 869.80K | 743.10K | 1.48M | 2.40M |
| Total Receivables | 27.10K | 224.30K | 9.50K | 109.30K | 125.70K |
| Inventory | 38.90K | 62.90K | 93.50K | 162.50K | 167.30K |
| Prepaid Expenses | 126.50K | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 18.80K | -- | 399.70K | -- | 468.70K |
| Total Current Assets | 456.60K | 1.16M | 1.25M | 1.75M | 3.16M |
|
|
|||||
| Total Current Assets | 456.60K | 1.16M | 1.25M | 1.75M | 3.16M |
| Net Property, Plant & Equipment | 1.16M | 1.14M | 1.32M | 1.58M | 1.84M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00 | -- | -- | -- | 3.80K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 109.10K | 48.10K | 48.20K | 48.00K | 48.50K |
| Total Assets | 1.73M | 2.35M | 2.61M | 3.38M | 5.05M |
|
|
|||||
| Total Accounts Payable | 450.40K | 518.20K | 471.30K | 350.80K | 480.80K |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | 399.70K | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 674.20K | 546.30K | 500.50K | 495.50K | 491.40K |
| Total Finance Division Other Current Liabilities | 260.60K | 382.70K | 407.00K | 386.20K | 337.70K |
| Total Other Current Liabilities | 260.60K | 382.70K | 407.00K | 386.20K | 337.70K |
| Total Current Liabilities | 1.39M | 1.45M | 1.78M | 1.23M | 1.31M |
|
|
|||||
| Total Current Liabilities | 1.39M | 1.45M | 1.78M | 1.23M | 1.31M |
| Long-Term Debt | 496.20K | 521.10K | 507.10K | 505.90K | 511.90K |
| Short-term Debt | -- | -- | 399.70K | -- | -- |
| Capital Leases | 199.50K | 234.70K | 368.20K | 499.20K | 629.20K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 2.08M | 2.20M | 2.65M | 2.24M | 2.45M |
|
|
|||||
| Common Stock & APIC | 88.71M | 94.38M | 92.06M | 92.99M | 95.02M |
| Retained Earnings | -88.87M | -93.99M | -91.86M | -91.60M | -92.14M |
| Treasury Stock & Other | -189.00K | -244.30K | -231.60K | -244.40K | -279.40K |
| Total Common Equity | -351.00K | 144.30K | -40.20K | 1.14M | 2.60M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -351.00K | 144.30K | -40.20K | 1.14M | 2.60M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -351.00K | 144.30K | -40.20K | 1.14M | 2.60M |
|
|
|||||